 | Wall Street Sees Vir Biotechnology Bouncing Hard
marketbeat.com - September 16 at 10:11 AM |
 | Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic
bloomberg.com - January 15 at 12:15 AM |
 | Vir Biotechnology (VIR) Shares Cross Above 200 DMA
nasdaq.com - January 14 at 7:04 PM |
 | Vir Biotechnology (NASDAQ:VIR) Stock Price Up 10.9%
americanbankingnews.com - January 13 at 9:41 PM |
| Herbert Virgin Sells 3,805 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock
americanbankingnews.com - January 13 at 8:50 PM |
| Vir Biotechnology (NASDAQ:VIR) versus Precision BioSciences (NASDAQ:DTIL) Financial Contrast
americanbankingnews.com - January 13 at 5:16 AM |
| Interesting VIR Put And Call Options For February 19th
nasdaq.com - January 12 at 3:11 PM |
 | GSK, Vir to test antibody for COVID-19 treatment
msn.com - January 12 at 6:37 AM |
 | TOP NEWS: GSK, Vir To Probe Second Virus Antibody In NHS-Backed Trial
lse.co.uk - January 12 at 6:37 AM |
 | BRIEF-GSK, Vir Biotechnology Announce Study To Evaluate Vir-7832 In Early Treatment Of COVID-19
reuters.com - January 12 at 6:37 AM |
|
| First Week of July 16th Options Trading For Vir Biotechnology
nasdaq.com - January 11 at 3:35 PM |
| Noteworthy Monday Option Activity: VIR, NBIX, GRWG
nasdaq.com - January 11 at 3:35 PM |
 | JPM Day 1: The 19-day Covid deal, how global-focused biotech wins, last-minute news and more
bizjournals.com - January 11 at 10:45 AM |
| Vir Biotechnology (NASDAQ:VIR) Stock Price Down 5.8%
americanbankingnews.com - January 8 at 8:46 PM |
| Critical Comparison: Axcella Health (NASDAQ:AXLA) vs. Vir Biotechnology (NASDAQ:VIR)
americanbankingnews.com - January 8 at 7:30 PM |
| Vir Biotechnology Target of Unusually Large Options Trading (NASDAQ:VIR)
americanbankingnews.com - January 8 at 1:10 PM |
| Economic Forecast: Where biotech goes next after a banner year
bizjournals.com - January 8 at 9:10 AM |
| Vir Biotechnology (NASDAQ:VIR) Trading 11.4% Higher
americanbankingnews.com - January 7 at 7:00 PM |
| OHSU's HIV vaccine candidate begins first clinical trial in humans
bizjournals.com - January 6 at 6:45 PM |
 | Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform
finance.yahoo.com - January 6 at 8:40 AM |
| Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 8:28 AM |
| Varun Grover, Vir Das Stand in Solidarity With Comedian Held for 'Indecent Remarks' on Hindu Deities
msn.com - January 4 at 3:28 AM |
| Reviewing Kodiak Sciences (NASDAQ:KOD) & Vir Biotechnology (NASDAQ:VIR)
americanbankingnews.com - January 1 at 5:12 PM |
| Zacks: Brokerages Expect Vir Biotechnology, Inc. (NASDAQ:VIR) Will Post Quarterly Sales of $2.65 Million
americanbankingnews.com - January 1 at 2:32 AM |
| Brokerages Anticipate Vir Biotechnology, Inc. (NASDAQ:VIR) to Post -$0.72 Earnings Per Share
americanbankingnews.com - December 30 at 5:14 PM |
| Vir, biotech firm researching coronavirus, to take part of Dropbox HQ
msn.com - December 29 at 11:12 PM |
| $2.65 Million in Sales Expected for Vir Biotechnology, Inc. (NYSE:VIR) This Quarter
americanbankingnews.com - December 29 at 2:46 AM |
| Vir Biotechnology, Inc. (NYSE:VIR) Expected to Post Earnings of -$0.72 Per Share
americanbankingnews.com - December 27 at 1:20 PM |
| Vir Biotechnology, Inc. (NYSE:VIR) Receives Average Rating of "Hold" from Analysts
americanbankingnews.com - December 26 at 5:26 PM |
| Vir Biotechnology's (VIR) Sell Rating Reaffirmed at Robert W. Baird
americanbankingnews.com - December 25 at 8:04 AM |
| Insider Selling: Vir Biotechnology, Inc. (NYSE:VIR) EVP Sells 3,805 Shares of Stock
americanbankingnews.com - December 23 at 8:48 PM |
| Are Options Traders Betting on a Big Move in in Vir Biotechnology (VIR) Stock?
finance.yahoo.com - December 22 at 12:55 PM |
|
| The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
finance.yahoo.com - December 18 at 10:52 AM |
| The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
finance.yahoo.com - December 18 at 10:52 AM |
| Vir, GSK's experimental COVID-19 treatment moves into a Phase 3 clinical trial
finance.yahoo.com - December 18 at 10:52 AM |
| Vir, GSK's experimental COVID-19 treatment moves into a Phase 3 clinical trial
finance.yahoo.com - December 18 at 10:52 AM |
| Vir Biotechnology Appoints Jeffrey Hatfield to its Board of Directors
finance.yahoo.com - December 10 at 12:33 PM |
| Future Vaccines Have 'High Barrier' to Cross, Vir CEO Says
msn.com - December 5 at 9:22 PM |
| Is Vir Biotechnology (VIR) A Good Stock To Buy Now?
finance.yahoo.com - December 2 at 8:16 PM |
| Here are the latest updates on coronavirus treatments and the Moderna, Pfizer and other vaccines
msn.com - November 30 at 3:34 PM |
| Biotech IPOs close to beating Covid-19
nasdaq.com - November 25 at 6:43 PM |
| Peter Thiel Gets Board Seat at AbCellera as IPO Nears
msn.com - November 19 at 1:09 PM |
| Analysts Have Just Cut Their Vir Biotechnology, Inc. (NASDAQ:VIR) Revenue Estimates By 20%
finance.yahoo.com - November 16 at 12:33 PM |
| Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Trimming Their Forecasts
finance.yahoo.com - November 13 at 12:08 PM |
| As other Covid drugs grab headlines, this Bay Area company picks its spot to defeat virus
bizjournals.com - November 10 at 8:38 PM |
| Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 10 at 8:38 PM |
 | Vir Biotechnology: Small-Cap Player That Lets Others Do The Heavy Lifting
seekingalpha.com - November 7 at 12:54 PM |
| Vir Biotechnology Publishes New Research Characterizing Variation in the SARS-CoV-2 Spike Protein and Virulence of a Prevalent Immune Evasion Variant, N439K
finance.yahoo.com - November 6 at 11:46 AM |
| Lilly Races Ahead on a Single-Antibody Covid-19 Treatment
bloomberg.com - October 29 at 6:53 AM |
| 27 pharma execs involved in the hunt for COVID-19 vaccines have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most from Regeneron ...
msn.com - October 28 at 5:48 PM |
| Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2020 Financial Results on November 10, 2020
finance.yahoo.com - October 27 at 7:41 PM |
